In contrast, increased levels of CXCR4 protein triggers homing of CML LSCs to the bone marrow microenvironment which induces quiescence and TKI-resistance [42, 43]. Here, CXCR4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.